Skip to Main Content
Skip Nav Destination

IJMSC Editorial Board and Publishing Staff

The IJMSC editorial board is a critical resource in support of the Editor in Chief as well as the aims and scope of the journal. Members of the editorial board serve in an important advisory capacity to the Editor in Chief and the rest of the editorial team on all matters affecting the journal, and contribute reviews of manuscripts as needed. The current editorial board comprises individuals from across North America and Europe, with plans to add representation from other parts of the world as members complete their terms.

Editor in Chief

Francois Bethoux, MD
Mellen Center for Multiple Sclerosis, Cleveland Clinic, Ohio, USA

Dr. Bethoux is Director of Rehabilitation Services at the Mellen Center for MS Treatment and Research, and Medical Director of the Arts and Medicine Institute, at the Cleveland Clinic Foundation. He is also Professor of Medicine at the Cleveland Clinic Lerner College of Medicine. Dr. Bethoux received his MD from Claude Bernard University in Lyon, France. His research interests include neurorehabilitation, spasticity management, and interventions (including therapeutic arts) to improve walking in persons with MS.

Associate Editor

Mary Alissa Willis, MD
University of Mississippi Medical Center, Jackson, Mississippi, USA

Dr. Willis is Associate Professor and Chair of Neurology at the University of Mississippi Medical Center. She completed a clinical neuroimmunology fellowship and previously served as Medical Director at the Mellen Center for Multiple Sclerosis at Cleveland Clinic. Her specific areas of interest include medical education, spasticity management, and comprehensive care of the MS patient.

Board Members

Ted Brown, MD, MPH
Evergreen Neuroscience Institute and Medical Center, Kirkland, Washington, USA

Dr. Brown is Director of Neurorehabilitation at the MS Center at Evergreen, Evergreen Hospital Medical Center, Kirkland, Washington. His clinical emphasis is on maximizing function and mobility in MS patients, and his research interests are in clinical trials and rehabilitation interventions for MS. He received his MD from Harvard University and his MPH from the University of California at Berkeley, and is certified by the American Board of Physical Medicine and Rehabilitation.

Marcia Finlayson, PhD, OT Reg (Ont), OTR
School of Rehabilitation Therapy, Queen’s University, Kingston, Ontario, Canada

Dr. Finlayson is Director and Vice-Dean (Health Sciences), School of Rehabilitation Therapy, Queen’s University, Kingston, Ontario, Canada. Her research program focuses on developing, implementing, and evaluating self-management programs and rehabilitation services to enhance the health and well-being of people affected by MS. Her work focuses primarily on fatigue management, falls prevention, and issues related to aging with MS. She received her PhD in community health sciences from the University of Manitoba.

Frederick W. Foley, PhD
Yeshiva University, Bronx, New York, USA
Holy Name Medical Center, Teaneck, New Jersey, USA

Dr. Foley is Professor of Psychology at the Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, New York, and Director of Psychosocial Research and Neuropsychology at Holy Name Medical Center Multiple Sclerosis Center, Teaneck, New Jersey. His work in MS has focused on developing psychological based treatments for anxiety, depression, pain, and sexual function, and developing symptomatic screening measures. He received his PhD in clinical psychology from Fordham University.

Kathleen Fuchs, PhD, ABPP
James Q. Miller MS Clinic at University of Virginia Health System, Charlottesville, Virginia, USA

Dr. Fuchs is Associate Professor of Clinical Neurology in the Department of Neurology at the University of Virginia (UVA), Charlottesville. She has been part of the UVA James Q. Miller MS Clinic since it was founded. She is board certified in clinical neuropsychology, and she does cognitive assessments of individuals with MS as well as psychotherapy. She earned her PhD at the University of Houston and completed an internship in clinical psychology at the University of Chicago Medical Center and a postdoctoral fellowship in clinical neuropsychology at UVA.

Christoph Heesen, MD
Multiple Sclerosis Day Hospital, Institute of Neuroimmunology and Clinical MS Research
Department of Neurology, University Medical Center, Hamburg, Germany

Dr. Heesen is Head of the Multiple Sclerosis Day Hospital and Outpatient Unit and Deputy Head of the Institute of Neuroimmunology and Clinical MS Research, University Medical Center, Hamburg, Germany. His main research interests are psychoneuroimmunology and behavioral interventions in MS, with a special focus on shared decision making. He is an active member of Rehabilitation in Multiple Sclerosis (RIMS), the European network for best practice and research in MS rehabilitation.

Beverly A. Layton

Beverly A. Layton, RN, BSN, CCRC, MSCN
Multiple Sclerosis Nurse Consultant, Birmingham, Alabama, USA

Ms. Layton has been working in the MS field since 1987 when she joined the University of Alabama at Birmingham (UAB) MS Center as the Research Nurse Coordinator. With a chief research interest in the treatment of MS, she served as the coordinator on numerous therapeutic clinical drug trials. She retired from UAB and continues to work as a Multiple Sclerosis Nurse Consultant. Ms. Layton has been a member of the IOMSN since 1998; she previously served as Secretary and Treasurer and continues to serve on several committees. Ms. Layton remains active in the ACRP, CMSC, and the NMSS Chapter AL/MS. She has a volunteer position at the UAB MS Center where she is a mentor in the nurses’ role in management of patients with MS.

James Marriott, MD, FRCPC
Department of Internal Medicine (Neurology), University of Manitoba, Winnipeg, Canada

Dr. Marriott’s research interests revolve around clinical trials to develop new disease-modifying and symptomatic therapies for MS patients. He is specifically interested in investigator-initiated trials to study novel agents to treat symptoms such as MS-related fatigue. He is also interested in clinical trial design and developing better endpoints for evaluating MS disability. In addition, he is interested in how clinical trial data are incorporated into general medical practice and the effect of therapies in real-world settings.

Lori Mayer, MSN, DNP(s), MSCN, CCRP, RN
MS Clinic of Central Texas, Round Rock, Texas, USA

Dr. Mayer is the Director of Medical Research for the MS Clinic of Central Texas (Austin area). Her responsibilities include managing MS clinical research programs and providing patient-centered care for clinical trial participants. She has written MS protocols for clinical trials and has published articles in neurologic journals. She holds a Doctor of Nursing Practice degree, is currently MS-certified, has served as past board member of the International Organization of MS Nurses (IOMSN), and is currently Research chair for the IOMSN, as well as an editor of

Sarah A. Morrow, MD, MSc, FRCPC
Department of Clinical Neurological Sciences, Western University, London Health Sciences Centre, Ontario, Canada

Dr. Morrow is an Associate Professor of Neurology in the Department of Clinical Neurological Sciences at Western University in London, Ontario, Canada. In addition to working in the MS clinic at London Health Sciences Center, she has established the first MS cognitive clinic in Canada. Her research focuses on cognitive impairment in MS, and the use of corticosteroids for MS relapses.

Ahmed Z. Obeidat, MD, PhD
Medical College of Wisconsin, Milwaukee, Wisconsin, USA

Dr. Obeidat is Assistant Professor of Neurology at the Medical College of Wisconsin, Milwaukee, and Founding Director of the Neuroimmunology and MS Fellowship program. He received his medical degree with honors from Jordan University of Science and Technology in 2008 and a PhD in neuroscience and physiology from Wright State University, where he received the Graduate Student Excellence Award and served as a President’s Ambassador. He completed residency and fellowship training at the University of Cincinnati. Dr. Obeidat is interested in the intersection between arts, humanities, and neurology.

Carrie Lyn Sammarco, DNP, FNP-C, MSCN
Multiple Sclerosis Comprehensive Care Center, NYU Langone Medical Center, New York, New York, USA

Dr. Sammarco is a Nurse Practitioner at the Multiple Sclerosis Comprehensive Care Center of New York University (NYU) Langone Medical Center in Manhattan. She was awarded a Doctor of Nursing Practice degree from the Columbia University School of Nursing and the John Dystel Nursing Fellowship in MS (mentored by Dr. Aliza Ben-Zacharia). She has served as PI for several nursing-generated research projects at the NYU MS Center. Dr. Sammarco specializes in the management of highly complex MS symptoms and has a special interest in incorporating mindfulness techniques into her practice.

Dr. Sosnoff is Associate Dean for Research in the School of Health Professions and Professor in the Department of Physical Therapy, Rehabilitation Science, and Athletic Training at the University of Kansas Medical Center in Kansas City, Kansas. His professional background and training are in motor control and gerontology. Dr. Sosnoff’s current research focuses on the prediction, consequences, and prevention of walking, mobility, and balance impairments in individuals with MS.

Ex Officio

June Halper, MSN, ANP, FAAN
Consortium of Multiple Sclerosis Centers, Hackensack, New Jersey, USA

MJH Life Sciences®
2 Clarke Drive
Cranbury, NJ 08512, USA
Director, Sales – Noah Fishbein

Project Manager

Charlene Belsole, CCRP
Mellen Center for Multiple Sclerosis, Cleveland Clinic, Ohio, USA

Production Staff - MJH Life Sciences®
Editorial Director – Alicia Bigica
Editor – Erin Gyomber
Creative Director – Melissa Feinen
Senior Designer – Helena Coppola

Close Modal

or Create an Account

Close Modal
Close Modal